EPAT General Discussion, page-767

Next year key milestones outlook:

In 2017 we established PainChekTM as the world’s first pain assessment app using artificial intelligence and with regulatory clearance. The market has responded very positively and we now ideally positioned to build on the solid foundations created over the past year.

Key objectives for calendar year 2018 year are:

• - successful commercialization of the enterprise version of PainChekTM for Dementia in Australia and selected European markets;
  
  
• - obtaining FDA regulatory clearance of PainChekTM for Dementia in the USA;
  
  
• - developing and launching a consumer version of PainChekTM for Dementia;
  
  I see your point...